LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of Oczyesa®, octreotide subcutaneous depot (CAM2029),...
Read More Details
Finally We wish PressBee provided you with enough information of ( CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU )
Also on site :